- Release Date: 13/10/22 09:47
- Summary: Positive BTX 1702 Phase 1b/2 Clinical Study for Rosacea
- Price Sensitive: Yes
- Download Document 5.36MB
Ann: Positive BTX 1702 Phase 1b/2 Clinical Study for Rosacea
- There are more pages in this discussion • 100 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.0¢ |
Change
0.010(3.57%) |
Mkt cap ! $448.9M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 30.0¢ | 28.5¢ | $650.7K | 2.238M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 267429 | 28.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.0¢ | 143020 | 9 |
View Market Depth
| Last trade - 12.00pm 22/05/2024 (20 minute delay) ? |
|
|||||
|
Last
28.8¢ |
Change
0.010 ( 2.75 %) |
||||
| Open | High | Low | Volume | ||
| 29.5¢ | 30.0¢ | 28.5¢ | 681186 | ||
| Last updated 12.15pm 22/05/2024 ? | |||||
| BOT (ASX) Chart |